D72.0
Genetic anomalies of leukocytes
Clinical Classification Guidelines
Inclusion Terms
- Alder (granulation) (granulocyte) anomaly
- Alder syndrome
- Hereditary leukocytic hypersegmentation
- Hereditary leukocytic hyposegmentation
- Hereditary leukomelanopathy
- May-Hegglin (granulation) (granulocyte) anomaly
- May-Hegglin syndrome
- Pelger-Huët (granulation) (granulocyte) anomaly
- Pelger-Huët syndrome
Excludes Type 1
- Chédiak (-Steinbrinck)-Higashi syndrome (E70.330)
Medical Intelligence & Overview
Genetic anomalies of leukocytes refer to inherited conditions that affect the structure and function of white blood cells, also known as leukocytes. These conditions are usually present from birth and are often discovered during blood tests. Leukocytes play a key role in the immune system, helping the body fight infections. When these cells have genetic abnormalities, it can impact the immune response in various ways. Several syndromes and syndromic conditions fall under this category, including May-Hegglin syndrome and Pelger-Huët anomaly. These conditions are generally inherited and may have varying implications for health and immune function.
Causes & Symptoms
Clinical Causes: Inherited genetic mutations affecting leukocyte development and morphology Specific gene mutations associated with syndromes such as May-Hegglin and Pelger-Huët Autosomal dominant inheritance patterns in many cases Potential hereditary links observed in family medical histories
Key Symptoms: Altered appearance of white blood cells seen under a microscope Increased susceptibility to infections in some cases Bleeding tendencies if platelet function is also affected Asymptomatic presentation, often discovered incidentally during blood tests Potential mild bleeding or bruising
Diagnostic & Treatment
Diagnosis Path: Diagnosis of these genetic anomalies typically involves a detailed blood smear examination, where a microscope reveals abnormal leukocyte features such as hyposegmentation or hypersegmentation of nuclei. Additional laboratory tests may include genetic testing to identify specific mutations associated with these syndromes. Blood counts may show normal or slightly abnormal white blood cell levels, but the key feature is the morphological abnormality observed. A thorough medical history and family history can help clarify inheritance patterns and confirm the diagnosis.
Treatment Protocols: There is no specific treatment for most inherited leukocyte anomalies, as they often do not cause significant health issues. Management generally focuses on monitoring immune function and preventing infections. Regular medical check-ups and blood work may be recommended to observe any evolving symptoms. In cases where immune system impairment is significant, supportive therapies or prophylactic measures might be considered, but these are tailored to individual patient needs. Genetic counseling can also be valuable for affected families to understand inheritance and implications for relatives.
Clinical Advice & FAQs
Billing Guidance
Is D72.0 a billable ICD-10 code?
Yes, D72.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D72.0?
Clinical documentation must specify the nature of Genetic anomalies of leukocytes and any associated comorbidities for accurate reporting.
Cite this Clinical Reference